Clinical trials provide early access to potentially beneficial treatments, advance science, and play an integral role in developing new and improved treatments for brain tumors. Often, the lengthiest aspect of the drug approval process is finding people to participate in trials, even though the National Comprehensive Cancer Network (NCCN) believes the best management of any patient with cancer is a clinical trial.
Explore key terms, important questions to ask, and other educational resources about clinical trials as you navigate your brain tumor experience.
Review the collection of questions below about clinical trials. We encourage you to bring these questions with you to your next appointment. This content is provided by the National Cancer Institute.
The research world has its own set of lingo for the important work they do. Read our list of important terms to know as you familiarize yourself with clinical trials.
Clinical Research
Clinical research is medical research that involves people to test new treatments and therapies.
Clinical Trial
A clinical trial is a research study in which one or more human subjects are prospectively assigned to one or more interventions, which may include a placebo or other control to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.
Exclusion Criteria
Exclusion criteria are factors that do not allow someone to participate in a clinical trial.
Healthy Volunteer
A healthy volunteer is a person with no known significant health problems who participates in clinical research to test a new drug, device, or intervention.
Inclusion Criteria
Inclusion criteria are factors that allow someone to participate in a clinical trial.
Informed Consent
Informed consent explains risks and potential benefits about a clinical trial before someone decides whether to participate.
Patient Volunteer
A patient volunteer has a known health problem and participates in research to better understand, diagnose, treat, or cure that disease or condition.
Phases
Clinical trials are conducted in phases. The trials at each phase have a different purpose and help researchers answer different questions.
Placebo
A placebo is a pill or liquid that looks like the new treatment but does not have any treatment value from active ingredients.
Protocol
A protocol is a carefully designed plan to safeguard the participants’ health and answer specific research questions.
Principal Investigator
A principal investigator is a doctor who leads the clinical research team and, along with the other members of the research team, regularly monitors study participants’ health to determine the study’s safety and effectiveness.
Randomization
Randomization is the process by which two or more alternative treatments are assigned to volunteers by chance rather than by choice.
Single- or Double-blind Studies
Single- or double-blind studies, also called single- or double-masked studies, are studies in which the participants do not know which medicine is being used, so they can describe what happens without bias. In single-blind studies, you are not told what is being given, but the research team knows. In a double-blind study, neither you nor the research team are told what you are given; only the pharmacist knows. Members of the research team are not told which participants are receiving which treatment to reduce bias. If medically necessary, however, it is always possible to find out which treatment you are receiving.
Types of Clinical Trials
Courtesy: National Institutes of Health
Share quick, impactful stats about biomarker testing and inspire others to learn more.
It can be confusing and overwhelming to understand which clinical trial may be best for you or a loved one. Our Clinical Trial Finder tool allows you to search for a local clinical trial for your specific tumor type.
Sign up to receive updates and resources about biomarker testing, clinical trials, and more.
Have you enrolled in a clinical trial? NBTS wants to hear from you!
Watch our informative 30-minute video that breaks down clinical trials, including key terms and common questions, with the help of a leading expert in the field.
WATCH NOW